@misc{10902/23478,
year = {2021},
month = {5},
url = {http://hdl.handle.net/10902/23478},
abstract = {RESUMEN :
 INTRODUCCIÓN: La incidencia de tromboembolismo pulmonar (TEP) podría haberse incrementado durante la pandemia debido al confinamiento y a la enfermedad por coronavirus (COVID-19). El objetivo de este estudio es, entre otros, observar si este hecho se ha producido en el Hospital Universitario Marqués de Valdecilla (HUMV). MATERIAL Y MÉTODOS: Estudio observacional retrospectivo con una muestra de 111 pacientes diagnosticados de TEP entre enero y octubre de 2020, ambos inclusive. Además de la incidencia, se han analizado otras variables que nos permitieron caracterizar a los pacientes. Se compararon los resultados obtenidos con una muestra de 2018 en el HUMV. RESULTADOS: No se ha producido un aumento significativo de la incidencia de TEP (2.78%). Se ha observado un retraso en el diagnóstico de TEP en el Servicio de Urgencias (p<0.001), además de un aumento del porcentaje de ingreso en UCI (p=0.01), sin traducirse en un aumento de la mortalidad (p=0.299). Un 4.5% de los pacientes tuvieron enfermedad por coronavirus y su mortalidad fue del 66.67% (p=0.004). CONCLUSIONES: Existe la sospecha de un posible infradiagnóstico de TEP. A pesar de un mayor retraso del diagnóstico en Urgencias e ingreso en UCI, no se ha traducido en un aumento de la mortalidad. En los pacientes con la COVID-19 es importante sospechar TEP ante un empeoramiento de la sintomatología y parece que la enfermedad tromboembólica podría ser un factor pronóstico negativo.},
abstract = {ABSTRACT :
INTRODUCTION: The incidence of pulmonary thromboembolism (PE) may have 
increased during the pandemic due to the lockdown and the coronavirus disease 
(COVID-19). The objective of this study is to observe whether this event has occurred at 
the Marqués de Valdecilla University Hospital (HUMV) during COVID-19 pandemic, 
among other purposes.
MATERIAL AND METHODS: It is a retrospective observational study with a sample of 
111 patients diagnosed with PE between January and October 2020, both inclusive. In
addition to the incidence, other variables have been analyzed that allowed us to 
characterize the patients. The results obtained were compared with a 2018 sample at
the HUMV.
RESULTS: There has not been a significant increase in the incidence of PE (2.78%). A 
delay in the diagnosis of PE has been observed in the Emergency Department (p<0.001), 
in addition to a raise in the percentage of admission to the ICU (p=0.01), without 
implying an increase in mortality (p=0.299). 4.5% of the patients had coronavirus and 
their mortality rate was 66.67% (p=0.004).
CONCLUSION: There is a suspicion of a possible underdiagnosis of PE. Despite a longer 
delay in diagnosis in the Emergency Department and a higher admission to the ICU, this 
did not involve an increase in mortality. In patients with COVID-19, it is important to 
suspect PE when symptoms worsen and it seems that thromboembolic disease could be 
a negative prognostic factor.},
title = {Tromboembolismo pulmonar en la epidemia COVID-19},
author = {Fernández Caso, Melanie},
}